Panbela Therapeutics, Inc.
PBLA
$0.2603
-$0.0607-18.91%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.18M | -7.14M | -7.12M | -6.47M | -7.84M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 436.00K | -722.00K | 137.00K | 190.00K | -145.00K |
| Change in Net Operating Assets | 4.62M | 6.88M | -2.41M | 3.20M | 1.31M |
| Cash from Operations | -2.12M | -981.00K | -9.39M | -3.08M | -6.68M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 775.00K | -- | 0.00 | 400.00K |
| Cash from Investing | 0.00 | 775.00K | -- | 0.00 | 400.00K |
| Total Debt Issued | 2.20M | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -1.00M | 0.00 | 0.00 |
| Issuance of Common Stock | 0.00 | -- | 9.01M | 4.77M | -- |
| Repurchase of Common Stock | -- | -26.00K | -- | -1.00K | -19.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 26.00K | -926.00K | -24.00K | 0.00 |
| Cash from Financing | 2.20M | 0.00 | 7.08M | 4.75M | -19.00K |
| Foreign Exchange rate Adjustments | 3.00K | 3.00K | -6.00K | 2.00K | -2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 83.00K | -203.00K | -2.32M | 1.67M | -6.30M |